News & Updates

Show Multimedia Only

Lovastatin cream shows therapeutic potential in disseminated superficial actinic porokeratosis

29 Mar 2023

In the treatment of patients with disseminated superficial actinic porokeratosis (DSAP), the use of topical lovastatin 2% cream may help improve outcomes, with the addition of cholesterol having a limited benefit, according to a study.

Lovastatin cream shows therapeutic potential in disseminated superficial actinic porokeratosis

29 Mar 2023

No drawback to immediate complete revascularization in ACS

29 Mar 2023 by

Doing an immediate complete revascularization of coronary artery lesions is as safe as a staged complete revascularization approach in patients with acute coronary syndrome (ACS) and multivessel disease in the BIOVASC trial presented at ACC.23/WCC.

No drawback to immediate complete revascularization in ACS

29 Mar 2023

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

28 Mar 2023

Children born to mothers who used acetaminophen during pregnancy do not appear to have poor cognitive development at 4 years of age, as shown in a study.

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

28 Mar 2023

Promising treatment options for chronic hives on the horizon

28 Mar 2023 by

Dupilumab, barzolvolimab, and remibrutinib appear to help reduce disease activity in patients with chronic spontaneous urticaria, according to the results of three studies presented at AAAAI 2023.

Promising treatment options for chronic hives on the horizon

28 Mar 2023

Temozolomide beyond 6 months tied to better survival in glioblastoma

28 Mar 2023

More than 6 cycles of extended adjuvant temozolomide (TMZ) therapy may result in better overall (OS) and progression-free survival (PFS) in patients with glioblastoma multiform, suggests a study.

Temozolomide beyond 6 months tied to better survival in glioblastoma

28 Mar 2023

CGM improves glycaemic, neonatal outcomes in pregnant women with T1D

28 Mar 2023

Combining continuous glucose monitoring (CGM) with continuous subcutaneous insulin infusion (CSII) therapy helps keep blood glucose levels low throughout pregnancy and lower the rate of large for gestational age (LGA) delivery, according to a study.

CGM improves glycaemic, neonatal outcomes in pregnant women with T1D

28 Mar 2023

Biologics lower exacerbation rates in severe asthma, allergic rhinitis

28 Mar 2023 by

Treatment with either omalizumab (anti-immunoglobulin E [anti-IgE]) or nonomalizumab (non-anti-IgE) biologics reduced exacerbations in patients with severe asthma and allergic rhinitis, with the benefits being more evident among those taking nonomalizumab agents, according to the CHRONICLE trial presented at AAAAI 2023.

Biologics lower exacerbation rates in severe asthma, allergic rhinitis

28 Mar 2023

Low, moderate glucocorticoid doses beneficial in severe fever with thrombocytopenia syndrome

27 Mar 2023

Treatment with low-to-moderate doses of glucocorticoids appears to help reduce case fatality rate among severe fever with thrombocytopenia syndrome (SFTS) patients with severe disease, as shown in a retrospective study.

Low, moderate glucocorticoid doses beneficial in severe fever with thrombocytopenia syndrome

27 Mar 2023

Chemotherapy plus ICI treatment ups VTE risk in cancer patients

27 Mar 2023

Combination treatment with immune checkpoint inhibitors (ICI) and chemotherapy is associated with a higher risk of venous thromboembolic events (VTE) in adult cancer patients, reveals a study. In addition, a similar VTE disease course is seen after ICI exposure, irrespective of other immune-related adverse events (irAEs).

Chemotherapy plus ICI treatment ups VTE risk in cancer patients

27 Mar 2023

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

27 Mar 2023 by

Children who are allergic to peanuts may benefit from two immunotherapies, one oral and another epicutaneous or on-the-skin, which have demonstrated safety and efficacy in separate studies presented at the recent AAAAI 2023.

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

27 Mar 2023

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Lovastatin cream shows therapeutic potential in disseminated superficial actinic porokeratosis

Lovastatin cream shows therapeutic potential in disseminated superficial actinic porokeratosis

No drawback to immediate complete revascularization in ACS

No drawback to immediate complete revascularization in ACS

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

Promising treatment options for chronic hives on the horizon

Promising treatment options for chronic hives on the horizon

Temozolomide beyond 6 months tied to better survival in glioblastoma

Temozolomide beyond 6 months tied to better survival in glioblastoma

CGM improves glycaemic, neonatal outcomes in pregnant women with T1D

CGM improves glycaemic, neonatal outcomes in pregnant women with T1D

Biologics lower exacerbation rates in severe asthma, allergic rhinitis

Biologics lower exacerbation rates in severe asthma, allergic rhinitis

Low, moderate glucocorticoid doses beneficial in severe fever with thrombocytopenia syndrome

Low, moderate glucocorticoid doses beneficial in severe fever with thrombocytopenia syndrome

Chemotherapy plus ICI treatment ups VTE risk in cancer patients

Chemotherapy plus ICI treatment ups VTE risk in cancer patients

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

Oral, on-the-skin immunotherapies show promise against peanut allergy in children